N/A
15 Years
39 Years
15 Years
39 Years
Open (Enrolling)
Both
Fatigue, Hodgkin Lymphoma
Both
Fatigue, Hodgkin Lymphoma
Trial Information
Inclusion Criteria:
- Currently 18 years of age or older
- Alive without evidence of recurrent disease
- Must be off therapy (not on active treatment for HL or other malignancies)
- Must not be on any form of chemotherapy (oral or intravenous [IV])
- Provide informed consent
- Can read and understand English
- Treated with risk-adapted therapy which may include radiotherapy doses < 30 Gy
Exclusion Criteria:
- Evidence of a subsequent malignancy following lymphoma treatment
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Prevalence and severity of fatigue and its impact on functional outcomes
Outcome Time Frame:
1 year
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
091550
NCT ID:
NCT01228461
Start Date:
February 2010
Completion Date:
February 2011
Related Keywords:
- Fatigue
- Hodgkin Lymphoma
- Hodgkin Lymphoma Survivors
- Adolescent and Young Adults
- Fatigue
- Hodgkin Disease
- Lymphoma
Name | Location |
|---|---|
| Vanderbilt University Medical Center | Nashville, Tennessee 37232-2516 |
